Spruce Biosciences, Inc. (SPRB) — 10-Q Filings
All 10-Q filings from Spruce Biosciences, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Spruce Biosciences Faces Delisting, Cash Crunch Amid 55% Workforce Cut
— Aug 14, 2025 Risk: high
Spruce Biosciences, Inc. reported a significant net loss of $16.1 million for the six months ended June 30, 2025, compared to a net loss of $20.8 million for th -
Spruce Biosciences Q1 2025 10-Q Filed
— May 6, 2025 Risk: medium
Spruce Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position, including its money market fund in -
Spruce Biosciences Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Spruce Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial condition and results of operations, inc -
Spruce Biosciences Files Q2 2024 10-Q
— Aug 12, 2024 Risk: medium
Spruce Biosciences, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business operati -
Spruce Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: medium
SPRUCE BIOSCIENCES, INC. (SPRB) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Spruce Biosciences, Inc. filed a 10-Q report for the period ending
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX